Sample: Maternal blood
Results: 7–12 days
A maternal-blood prenatal screen that combines trisomy screening with the additional fetal-antigen-related information named in the catalogue. NIPT is a screening test, not a diagnosis; review findings and any follow-up with your clinician. BabyPeek is available free of charge as an add-on to UNITY packages.
• Screening for trisomy 13 (Patau syndrome)
• Screening for trisomy 18 (Edwards syndrome)
• Screening for trisomy 21 (Down syndrome)
• 22q11.2 deletion syndrome screening
• Fetal RhD status screening
The catalogue lists trisomies 13, 18 and 21, 22q11.2 deletion syndrome and fetal RhD status.
A maternal blood sample is listed.
Yes, fetal RhD status is named in the package description.
Results are available in 7–12 days, with a maximum turnaround of 12 days.
No. NIPT is screening; your clinician can advise if confirmatory testing is appropriate.
